Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
50
|
pubmed:dateCreated |
1992-1-30
|
pubmed:abstractText |
Human zeta-thrombin, a catalytically competent serine proteinase, arises from a single chymotryptic cleavage at Trp-148 in alpha-thrombin to generate two nonconvalently associated polypeptide segments designated zeta 1-thrombin (the 36-residue A-chain disulfide linked to B-chain residues B1-148) and zeta 2-thrombin (B149-259). We report here the expression of recombinant zeta 2-thrombin in Escherichia coli and the reconstitution of catalytically competent zeta-thrombin by combination of zeta 1-thrombin with recombinant zeta 2-thrombin. A DNA fragment encoding zeta 2-thrombin was cloned into a pATH2 expression vector as a trpE-zeta 2 fusion gene, in which a factor Xa cleavage site was inserted between the trpE and the zeta 2-thrombin gene. High-level expression of this fusion protein was achieved under the control of the E. coli trp promoter. The expressed zeta 2-thrombin was liberated from the fusion protein by factor Xa cleavage, reduced with DTT, and purified to homogeneity by reverse-phase HPLC. Oxidation of the reduced zeta 2-thrombin in the presence of 80 microM CuSO4 and 6 M urea at pH 8.15 yielded material that was indistinguishable on HPLC from zeta 2-thrombin isolated by resolution of human zeta-thrombin. Catalytically active zeta-thrombin was generated by combination of recombinant zeta 2-thrombin with zeta 1-thrombin that was isolated by resolution of human zeta-thrombin. Recombinant zeta-thrombin displayed catalytic activities, toward a small chromogenic substrate and fibrinogen, that were similar to those of alpha-thrombin prepared from human blood plasma and zeta-thrombin obtained by treatment of alpha-thrombin with chymotrypsin.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
30
|
pubmed:geneSymbol |
trp,
trpE
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11694-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1751488-Amino Acid Sequence,
pubmed-meshheading:1751488-Bacterial Proteins,
pubmed-meshheading:1751488-Base Sequence,
pubmed-meshheading:1751488-Catalysis,
pubmed-meshheading:1751488-Chromatography, High Pressure Liquid,
pubmed-meshheading:1751488-Cloning, Molecular,
pubmed-meshheading:1751488-DNA,
pubmed-meshheading:1751488-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:1751488-Escherichia coli,
pubmed-meshheading:1751488-Genetic Vectors,
pubmed-meshheading:1751488-Humans,
pubmed-meshheading:1751488-Molecular Sequence Data,
pubmed-meshheading:1751488-Operon,
pubmed-meshheading:1751488-Oxidation-Reduction,
pubmed-meshheading:1751488-Promoter Regions, Genetic,
pubmed-meshheading:1751488-Recombinant Fusion Proteins,
pubmed-meshheading:1751488-Thrombin
|
pubmed:year |
1991
|
pubmed:articleTitle |
Reconstitution of catalytically competent human zeta-thrombin by combination of zeta-thrombin residues A1-36 and B1-148 and an Escherichia coli expressed polypeptide corresponding to zeta-thrombin residues B149-259.
|
pubmed:affiliation |
Department of Biological Chemistry, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
|
pubmed:publicationType |
Journal Article
|